Concepedia

Efficacy and acceptability of anti-inflammatory eicosapentaenoic acid for cognitive function in Alzheimer’s dementia: A network meta-analysis of randomized, placebo-controlled trials with omega-3 fatty acids and FDA-approved pharmacotherapy

Ping‐Tao Tseng, Bing‐Syuan Zeng, Mein‐Woei Suen, Yi‐Cheng Wu, Kuan‐Pin Su

Brain Behavior and Immunity · 2023 · 37 citations · 53 references

Open access

References

53

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Matthew J. Page, Joanne E. McKenzie, Patrick M. Bossuyt et al. · BMJ · 2021 · 95K citations · Full text

Public Health, Internal Medicine, Meta-analysis +10

AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both

Beverley Shea, Barnaby C Reeves, George A. Wells et al. · BMJ · 2017 · 10.4K citations · Full text

Public Affairs, Health Policy, Evidence-based Practice +16

Lecanemab in Early Alzheimer’s Disease

Christopher H. van Dyck, Chad J. Swanson, Paul Aisen et al. · New England Journal of Medicine · 2022 · 5.2K citations · Full text

Life Sciences, Neurology, Neuroscience +17

Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019

Emma Nichols, Jaimie D Steinmetz, Kai Fukutaki et al. · The Lancet Public Health · 2022 · 5.1K citations · Full text

Medicine, Geriatric Medicine, Neurology +15

Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial

Georgia Salanti, A. E. Ades, John P. A. Ioannidis · Journal of Clinical Epidemiology · 2010 · 3.8K citations

Public Health, Biostatistics, Causal Inference +11